Article from 17.12.2024 | Last changed: 17.06.2025
Entry and occurrence of human pharmaceuticals in the environment
… conditions (5): Cardiovascular diseases (33%) Pain and inflammation (13%) Nervous system disorders (11%) Gastrointestinal diseases (7%) Hormonal regulation (6%) … worldwide in its UBA Database "Pharmaceuticals in the Environment" . By 2020, investigations of samples from 89 countries worldwide detected 992 pharmaceutical … directive adopted Review of the lists of pollutants affecting surface waters and gr Related contents Umweltwirkungen von Arzneistoffen Arzneimittelrückstände in der …